Patents by Inventor Guisheng Zhou

Guisheng Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTELLIGENT ILLUMINATION SEEDLING INCUBATOR FOR SORGHUM CULTURE
    Publication number: 20230292676
    Abstract: Disclosed is an intelligent illumination seedling incubator for sorghum culture. The incubator comprises an incubator body and a culture component. At least one installation opening is formed in the forward side of the incubator body. The culture component comprises culture trays and a vertically arranged connecting shaft which is connected to the incubator body. A plurality of non-circular support pillars are arranged on the connecting shaft at intervals in the height direction. The culture trays are installed in the incubator body through the installation opening. A clamping opening is formed in the culture tray. A connecting sink with the same shape as the support pillar is formed in the downward end of the culture tray inside the clamping opening. After the culture tray is clamped into the connecting shaft through the clamping opening, the culture tray is exactly inserted on the support pillar through the connecting sink.
    Type: Application
    Filed: March 14, 2023
    Publication date: September 21, 2023
    Applicant: YANGZHOU UNIVERSITY
    Inventors: Yanqing WU, Jiao LIU, Guisheng ZHOU
  • Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
    Patent number: 8785442
    Abstract: The present invention relates to a compound as antagonist of LPA receptor, and a pharmaceutical composition comprising the same. The present invention also relates to the use of the compound and the composition, and a method of using the compound to treat, prevent or diagnose diseases, disorders or conditions associated with one or more of the LPA receptors.
    Type: Grant
    Filed: January 30, 2011
    Date of Patent: July 22, 2014
    Assignee: Curegenix, Inc.
    Inventors: Songzhu An, Chufang Li, Guisheng Zhou, Chen Huang
  • COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITION, AND USE THEREOF
    Publication number: 20140031353
    Abstract: The present invention relates to a compound as antagonist of LPA receptor, and a pharmaceutical composition comprising the same. The present invention also relates to the use of the compound and the composition, and a method of using the compound to treat, prevent or diagnose diseases, disorders or conditions associated with one or more of the LPA receptors.
    Type: Application
    Filed: January 30, 2011
    Publication date: January 30, 2014
    Applicant: CUREGENIX, INC.
    Inventors: Songzhu An, Chufang Li, Guisheng Zhou, Chen Huang
  • Phosphatases which activate map kinase pathways
    Publication number: 20100273862
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Application
    Filed: January 22, 2007
    Publication date: October 28, 2010
    Applicants: Amgen Inc., Baylor College of Medicine
    Inventors: John W. Belmont, Frederick A. Fletcher, Alice J. Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Phosphatases which activate map kinase pathways
    Patent number: 7195902
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: March 27, 2007
    Assignees: Amgen Corporation, Baylor College of Medicine
    Inventors: John W. Belmont, Frederick A. Fletcher, Alice J. Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Phosphatases which activate map kinase pathways
    Patent number: 6900043
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Grant
    Filed: September 20, 2000
    Date of Patent: May 31, 2005
    Assignee: Amgen Inc.
    Inventors: John W. Belmont, Frederick A. Fletcher, Alice J. Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Phosphatases which activate map kinase pathways
    Publication number: 20050014222
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Application
    Filed: March 18, 2004
    Publication date: January 20, 2005
    Inventors: John Belmont, Frederick Fletcher, Alice Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou